Portuguese Blueberry Shows Potent Anti-Inflammatory Effect in Colitis Animal Model

Portuguese Blueberry Shows Potent Anti-Inflammatory Effect in Colitis Animal Model
An active ingredient of a specific type of Portuguese blueberry shows increased anti-inflammatory effects in the intestines of an animal model with colitis when compared to mesalamine (5-ASA), a common drug used by inflammatory bowel disease (IBD) patients, new research shows. The study, “Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model,” was published in the journal PLOS One. Although the number of therapeutic options for IBD has increased, they still carry the burden of certain adverse effects. More efficient and safer therapies are needed. In this context, the use of natural products and dietary components for managing inflammatory diseases such as IBD has gained attention. Scientific proof of their effectiveness has been scarce, though. “Blueberries are among the fruits with potential health benefits associated with their high content in anthocyanins, a group of flavonoids widespread in human diet, which have been reported as potential therapeutic agents for several inflammatory diseases, including IBD,” researchers from Portugal wrote. Anthocyanins, a member of the flavonoids group of phytochemicals, are predominant in teas, honey, wines, fruits, vegetables, nuts, olive oil, cocoa, and cereals. The therapeutic value of anthocyanins for IBD as an approved drug needs further investigation. Notably, a recent study showed that eating be
Subscribe or to access all post and page content.